Cargando…

p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.

p53 status was investigated in 99 patients with squamous cell carcinoma of the head and neck region uniformly treated with accelerated radiotherapy and in whom tumour cell proliferation and DNA aneuploidy were assessed using bromodeoxyuridine (BrdUrd) incorporation and flow cytometry (FCM). Seventy-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, G. D., Richman, P. I., Dische, S., Saunders, M. I., Robinson, B., Daley, F. M., Ross, D. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033843/ https://www.ncbi.nlm.nih.gov/pubmed/7779719

Ejemplares similares

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.
por: Saunders, M. I., et al.
Publicado: (1996)

Continuous, hyperfractionated, accelerated radiotherapy (CHART).
por: Dische, S., et al.
Publicado: (1989)

Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
por: Bennett, M. H., et al.
Publicado: (1992)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
por: Ataman, Ö U, et al.
Publicado: (2001)

A drug for improved radiosensitization in radiotherapy.
por: Dische, S., et al.
Publicado: (1980)

Aberrant expression of cyclin A in head and neck cancer
por: Lotayef, M, et al.
Publicado: (2000)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
por: Brewczyński, Adam, et al.
Publicado: (2020)

Improved Normal Tissue Sparing in Head and Neck Radiotherapy Using Biological Cost Function Based-IMRT
por: Anderson, N., et al.
Publicado: (2011)

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M, et al.
Publicado: (2022)

Management of Adverse Effects Following Breast Radiotherapy: the report of the Maher Committee of the Royal College of Radiologists
por: Dische, S
Publicado: (1996)

Current strategies in radiotherapy of head and neck cancer
por: Pütz, M., et al.
Publicado: (2012)

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
por: Qian, Jack M., et al.
Publicado: (2021)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Oral complications of radiotherapy in the head and neck
por: Jham, Bruno Correia, et al.
Publicado: (2015)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer.
por: Tanner, N. S., et al.
Publicado: (1981)

Comparison of oral candidiasis characteristics in head-and-neck cancer patients before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2023)

Technical Advances and Pitfalls in Head and Neck Radiotherapy
por: Parvathaneni, Upendra, et al.
Publicado: (2012)

Defining the target for radiotherapy of head and neck cancer
por: Nuyts, S.
Publicado: (2007)

Novel p53 therapies for head and neck cancer
por: Castellanos, Mario R., et al.
Publicado: (2016)

Biological Evaluation of Grid versus 3D Conformal Radiotherapy in Bulky Head and Neck Cancer
por: Alanizy, Najah Abdulmuneem, et al.
Publicado: (2022)

Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000)

The Role of p53 and MDM2 in Head and Neck Cancer
por: Denaro, N., et al.
Publicado: (2011)

Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
por: Zahid, Mohammad U., et al.
Publicado: (2021)

Development of an optimum photon beam model for head‐and‐neck intensity‐modulated radiotherapy
por: Webster, Gareth J, et al.
Publicado: (2007)

Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy
por: Zapata, I., et al.
Publicado: (2019)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy
por: Maahs, Lucas, et al.
Publicado: (2022)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2019)

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
por: van der Heijden, Martijn, et al.
Publicado: (2020)

Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers
por: Baruah, P, et al.
Publicado: (2015)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

Utilization of custom electron bolus in head and neck radiotherapy
por: Kudchadker, R. J., et al.
Publicado: (2003)

Role of radiotherapy in the treatment of metastatic head and neck cancer
por: Ordoñez, Rafael, et al.
Publicado: (2019)

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
por: Giraud, Paul, et al.
Publicado: (2019)

Head and neck radiotherapy - A risk factor for anaesthesia?
por: Jain, Deepshikha, et al.
Publicado: (2020)

Impact of delays in radiotherapy of head and neck cancer on outcome
por: Žumer, Barbara, et al.
Publicado: (2020)

Oral management strategies for radiotherapy of head and neck cancer
por: Kawashita, Yumiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fapmg3q2lvgtsclnpia69jpf3p